C81.10
Nodular sclerosis Hodgkin lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Nodular sclerosis Hodgkin lymphoma is a type of cancer that originates in the lymphatic system. It's characterized by the presence of abnormal lymphoma cells within lymph nodes, especially in the chest, neck, or underarm areas. The condition is most commonly diagnosed in young adults and is generally considered one of the more treatable forms of Hodgkin lymphoma. While the term 'unspecified site' indicates that the exact location within the body hasn't been pinpointed, the disease primarily affects lymph nodes in the upper parts of the body. Early detection and treatment options have significantly improved survival rates for individuals diagnosed with this condition.
Causes & Symptoms
Clinical Causes: Genetic predisposition or family history of lymphoma Exposure to certain infections, notably the Epstein-Barr virus (EBV) History of other autoimmune diseases Previously undergone radiation therapy Environmental factors such as exposure to certain chemicals
Key Symptoms: Swelling or painless lumps in the neck, armpits, or collarbone area Persistent fever without obvious cause Night sweats, often severe enough to disrupt sleep Unexplained weight loss Itchy skin or skin rashes Fatigue or general weakness Shortness of breath or cough, if the lymph nodes in the chest are enlarged Loss of appetite
Diagnostic & Treatment
Diagnosis Path: Biopsy: A sample of lymph node tissue is examined under a microscope for the presence of Hodgkin Reed-Sternberg cells, characteristic of Hodgkin lymphoma. Imaging tests: CT scans, PET scans, or MRI scans help identify the size and location of affected lymph nodes and other tissues. Blood tests: These evaluate overall health and detect signs of disease progression or impact on organs. Bone marrow biopsy: Sometimes necessary if the disease has spread to the marrow. Laboratory tests: To assess overall health and organ function.
Treatment Protocols: Chemotherapy: The use of powerful drugs to target and eliminate cancer cells throughout the body. Radiation therapy: Targeted high-energy rays are used to destroy cancer cells in specific areas, often combined with chemotherapy. Immunotherapy: Newer treatments that help the body's immune system recognize and attack lymphoma cells. Stem cell transplant: Considered in cases where the disease is aggressive or has relapsed; involves replacing affected or damaged bone marrow. Targeted therapy: Medications designed to interfere with specific molecules involved in cancer growth and progression.
Clinical Advice & FAQs
Billing Guidance
Is C81.10 a billable ICD-10 code?
Yes, C81.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.10?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference